These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8109214)

  • 21. Efficacy of ciprofloxacin and dexamethasone in experimental pseudomonas endophthalmitis.
    Kim IT; Chung KH; Koo BS
    Korean J Ophthalmol; 1996 Jun; 10(1):8-17. PubMed ID: 8755196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model.
    Kowalski RP; Romanowski EG; Mah FS; Yates KA; Gordon YJ
    Am J Ophthalmol; 2005 Sep; 140(3):497-504. PubMed ID: 16083841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enoxacin therapy for experimental pseudomonas keratitis.
    Esposito S; Thadepalli H; Benler HA; Chuah SK
    J Chemother; 1991 Jun; 3(3):147-51. PubMed ID: 1919652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and ocular penetration of sparfloxacin in experimental streptococcal endophthalmitis.
    Cochereau-Massin I; Bauchet J; Marrakchi-Benjaafar S; Saleh-Mghir A; Faurisson F; Vallois JM; Vallee E; Pocidalo JJ
    Antimicrob Agents Chemother; 1993 Apr; 37(4):633-6. PubMed ID: 8388193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of experimental Staphylococcus epidermidis endophthalmitis with oral trovafloxacin.
    Ng EW; Samiy N; Ruoff KL; Cousins FV; Hooper DC; von Gunten S; D'Amico DJ; Baker AS
    Am J Ophthalmol; 1998 Aug; 126(2):278-87. PubMed ID: 9727522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of topical ceftazidime on pseudomonas keratitis in rabbits.
    Kremer I; Robinson A; Braffman M; Drucker M; Goldenfeld M; Samra Z; Myszne-Daye N; Gaton D; Savir H
    Cornea; 1994 Jul; 13(4):360-3. PubMed ID: 7924338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The comparison of fluoroquinolones to nonfluoroquinolone antibacterial agents for the prevention of endophthalmitis in a rabbit model.
    Kowalski RP; Romanowski EG; Shanks RM; Mah FS
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):604-8. PubMed ID: 22925112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ocular distribution of lomefloxacin 0.3% after a single instillation in the infected eye of pigmented rabbits.
    Elena PP; Jauch A
    J Ocul Pharmacol Ther; 1997 Dec; 13(6):551-8. PubMed ID: 9436158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model.
    Kowalski RP; Romanowski EG; Mah FS; Yates KA; Gordon YJ
    Am J Ophthalmol; 2004 Jul; 138(1):33-7. PubMed ID: 15234279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zymar (Gatifloxacin 0.3%) shows excellent Gram-negative activity against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand White rabbit keratitis model.
    Mah FS; Romanowski EG; Kowalski RP; Yates KA; Gordon YJ
    Cornea; 2007 Jun; 26(5):585-8. PubMed ID: 17525656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of corneal collagen shields as a drug delivery device for the treatment of experimental Pseudomonas keratitis.
    Silbiger J; Stern GA
    Ophthalmology; 1992 Jun; 99(6):889-92. PubMed ID: 1630778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of efficiency of intravitreal ceftazidime and intravitreal cefepime in the treatment of experimental Pseudomonas aeruginosa endophthalmitis.
    Deniz N; Aydemir O; Güler M; Akpolat N; Kizirgil A
    Indian J Ophthalmol; 2013 Sep; 61(9):525-7. PubMed ID: 24104717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meta-analysis of six clinical phase III studies comparing lomefloxacin 0.3% eye drops twice daily to five standard antibiotics in patients with acute bacterial conjunctivitis.
    Jauch A; Fsadni M; Gamba G
    Graefes Arch Clin Exp Ophthalmol; 1999 Sep; 237(9):705-13. PubMed ID: 10447643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo studies with sodium hyaluronate as a carrier for intraocular gentamicin.
    Moreira CA; Moreira AT; Armstrong DK; Jelliffe RW; Woodford CC; Liggett PE; Trousdale MD
    Acta Ophthalmol (Copenh); 1991 Feb; 69(1):50-6. PubMed ID: 1903016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-microbial Effect and in Vivo Ocular Delivery of Ciprofloxacin-loaded Liposome through Rabbit's Eye.
    Feghhi M; Sharif Makhmalzadeh B; Farrahi F; Akmali M; Hasanvand N
    Curr Eye Res; 2020 Oct; 45(10):1245-1251. PubMed ID: 32045531
    [No Abstract]   [Full Text] [Related]  

  • 36. [Lomefloxacin in treatment of infectious eye diseases].
    Maĭchuk IuF; Vakhova ES; Kononenko LA
    Antibiot Khimioter; 1998; 43(10):32-5. PubMed ID: 9825108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluoroquinolones: place in ocular therapy.
    Smith A; Pennefather PM; Kaye SB; Hart CA
    Drugs; 2001; 61(6):747-61. PubMed ID: 11398907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose response of experimental Pseudomonas endophthalmitis to ciprofloxacin, gentamicin, and imipenem: evidence for resistance to "late" treatment of infections.
    Davey PG; Barza M; Stuart M
    J Infect Dis; 1987 Mar; 155(3):518-23. PubMed ID: 3100661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical evaluation of ophthalmic lomefloxacin 0.3% in comparison with fortified cefazolin and gentamicin ophthalmic solutions in the treatment of presumed bacterial keratitis.
    Erjongmanee S; Kasetsuwan N; Phusitphoykai N; Puangsricharern V; Pariyakanok L
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S83-90. PubMed ID: 16083168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of experimental Pseudomonas corneal ulcers with enoxacin, a quinolone antibiotic.
    Sugar A; Cohen MA; Bien PA; Griffin TJ; Heifetz CL; Mehta S
    Arch Ophthalmol; 1986 Aug; 104(8):1230-2. PubMed ID: 3461752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.